Harlan Robins spent years as the co-founder and chief scientific officer of Adaptive Biotechnologies, helping build massive datasets to decode… Read More ...

Franklin Biotechnology Discovery has a much higher 13% five-year annualized return than a biotech index ETF’s 5.3% ...

Virtus Biotech ETF (BBP) gets a buy rating: equal-weight, quarterly rebalanced exposure to FDA-approved biotechs, deal ...

XBI is up nearly 80% over the past year, but has experienced a much larger maximum drawdown over the past five years. IHE has ...

Biotech stocks are having one of their best stretches in years. The iShares Biotechnology ETF IBB jumped nearly 5% Wednesday ...

Scribe Therapeutics’ one-time epigenetic treatment is designed to slash the adherence burden of chronic cholesterol-lowering ...

Scientists at the Department of Energy's Oak Ridge National Laboratory have created a platform that pinpoints genetic ...